Capstone Investment Advisors
CRDF icon

Capstone Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

Capstone Investment Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.5K Hold
51,190
– – ﹤0.01% 1636
2026
Q1 		$82.9K Hold
51,190
– – ﹤0.01% 1549
2025
Q4 		$144K Hold
51,190
– – ﹤0.01% 1519
2025
Q3 		$105K Hold
51,190
– – ﹤0.01% 1872
2025
Q2 		$161K Hold
51,190
– – ﹤0.01% 1542
2025
Q1 		$161K Hold
51,190
– – ﹤0.01% 1281
2024
Q4 		$222K Hold
51,190
– – ﹤0.01% 1566
2024
Q3 		$137K Hold
51,190
– – ﹤0.01% 1669
2024
Q2 		$114K Hold
51,190
– – ﹤0.01% 1870
2024
Q1 		$273K Hold
51,190
– – ﹤0.01% 1879
2023
Q4 		$75.8K Hold
51,190
– – ﹤0.01% 1968
2023
Q3 		$71.2K Hold
51,190
– – ﹤0.01% 1986
2023
Q2 		$75.2K Hold
51,190
– – ﹤0.01% 1732
2023
Q1 		$84.5K Hold
51,190
– – ﹤0.01% 1391
2022
Q4 		$71.7K Hold
51,190
– – ﹤0.01% 1431
2022
Q3 		$79K Hold
51,190
– – ﹤0.01% 1586
2022
Q2 		$113K Hold
51,190
– – ﹤0.01% 1486
2022
Q1 		$127K Hold
51,190
– – ﹤0.01% 1823
2021
Q4 		$308K Sell
51,190
-1,159
-2% -$6.91K ﹤0.01% 1525
2021
Q3 		$349K Buy
52,349
+1,159
+2% +$7.28K ﹤0.01% 1622
2021
Q2 		$340K Sell
51,190
-6,030
-11% -$51.1K ﹤0.01% 1443
2021
Q1 		$530K Sell
57,220
-67,568
-54% -$821K ﹤0.01% 1255
2020
Q4 		$2.25M Buy
+124,788
New +$2.19M 0.01% 839

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Capstone Investment Advisors's CRDF Position: Q2 2026 in Review

Capstone Investment Advisors held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 51,190 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Capstone Investment Advisors first reported a position in CRDF in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.25M in Q4 2020. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Capstone Investment Advisors held 51,190 shares of Cardiff Oncology worth $66.5K as of Q2 2026.
  • Capstone Investment Advisors left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1636 holding.
  • Capstone Investment Advisors first reported a position in Cardiff Oncology in Q4 2020 and has held it in 23 quarters since.
  • Capstone Investment Advisors's Cardiff Oncology position peaked at $2.25M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.